HOUSTON, Jun 13, 2005 (BUSINESS WIRE) -- ChocoMed's UltraGourmet 24/7 Nutritional and Energy Bar Line Set to Debut at All Candy Expo(R)
Company also scheduled to introduce Schokinag Drinking Chocolate product
House of Brussels Chocolates ("Brussels" or "HBSL") (HBSL), today announced the official launch of its new 24/7 line of nutritional and energy bars through its subsidiary ChocoMed Inc. at the National Confectioners Association's All Candy Expo(R) being held June 14 - 16 in Chicago. The All Candy Expo(R) is the largest confectionary-only tradeshow in North America, with nearly 500 exhibitors, including House of Brussels Chocolates, and more than 20,000 attendees.
ChocoMed's line of Nutritional and Energy Bars were developed by House of Brussels Chocolate's Chief Operating Officer Guy DeBas, and come in an array of unprecedented high-quality flavors targeted to the health and wellness set. Made with only the finest and purest ingredients, 24/7 bars have no parallels and are the first truly gourmet nutritional and energy bars to hit the market.
Bill Donovan, Chairman of House of Brussels Chocolates stated, "We are very excited about the launch of our 24/7 line of nutritional and energy bars which represent an important step in our ongoing efforts to bring new and exciting products to consumers. Equally important, ChocoMed is now a revenue generating entity and we believe many opportunities exist for our company in the lucrative Health and Nutritional products sector over both the near and long-term. We are currently working closely, under non-disclosure agreements, with a number of companies to develop additional health and nutritional products using chocolate as a delivery agent and we are committed to capitalizing on our prospects."
In addition, the company will debut its new Schokinag drinking chocolate line at the All Candy Expo(R). In December 2004, House of Brussels Chocolates signed a multi-year co-packing and distribution agreement with Schokinag Chocolate North America Inc. Under terms of the agreement, House of Brussels Chocolates is responsible for the packing, marketing, selling and distributing Schokinag's entire line of baking chocolate, including their 7-flavor European Drinking Chocolate line.
About ChocoMed(TM), Inc. (www.chocomed.com)
ChocoMed, Inc., as a wholly owned subsidiary of House of Brussels Chocolates, has a mission to interface with third party companies, laboratories, or organizations that provide us nutritional and dietary supplements, functional foods and pharmaceutical compounds that are suitable candidates for hosting in chocolate-based products. ChocoMed will then bring these compounds to House of Brussels' manufacturing division who will attempt to "marry" these compounds with chocolate. If successful, the resulting nutraceuticals using chocolate as a delivery mechanism should prove to be an extremely marketable product.
About House of Brussels Chocolates Inc. (www.brusselschocolates.com)
For more than 20 years, House of Brussels Chocolates has manufactured and distributed high-end, award-winning chocolates. HBSL's signature product is the chocolate hedgehog, which marries the traditional Belgian symbol of good luck (i.e., the hedgehog) with taste (i.e., chocolate) for a strong customer appeal. In addition to its house brands, HBSL creates custom packaging, shaping and sizing as well as private labels for numerous North American retailers.
DeBas Chocolatier, a wholly owned subsidiary of HBSL, produces the Company's artisan chocolates. Every piece of DeBas chocolate is handcrafted to be a true work of art that is distinctly superior in quality and taste. DeBas is also famous for its panned chocolate products such as chocolate-covered coffee beans, fruits and nuts. The DeBas factory is certified as organic by the State of California, in addition to being Orthodox Kosher certified.
Safe Harbor: Certain statements in this news release regarding future expectations and plans may be regarded as "forward looking statements" as defined by federal law. Although the Company believes such statements are based on reasonable assumptions, there is no assurance that actual outcomes will not be materially different. Any such statements are made in reliance on the "safe harbor" protections provided under the Private Securities Reform Act of 1995. They are subject to various risks, including uncertainties regarding timing, and capital availability, as discussed in detail in House of Brussels quarterly and annual reports filed with the SEC.